Evidence map›Paper›PMID 20869812›Full record

Trial reportAddictive behaviors

Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.

Robert A Schnoll, Elisa Martinez, Kristina L Tatum, Marcella Glass, Albert Bernath, Daron Ferris, Patrick Reynolds

Abstract readClinical Trial, Phase IVMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Addictive behaviors. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A systematic review of the relationships between craving and smoking cessation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Development and Psychometric Evaluation of a Novel Measure of Nicotine E-cigarette Withdrawal for Use With Adolescents and Young Adults.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Robert A SchnollDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA 19104, USA. schnoll@mail.med.upenn.edu
Elisa Martinez
Kristina L Tatum
Marcella Glass
Albert Bernath
Daron Ferris
Patrick Reynolds
University of Pennsylvania · USAugusta University · USECRI Institute · USGeisinger Medical Center · USMount Sinai Medical Center · USRutgers Cancer Institute of New Jersey

Funding

Neuroimaging Abstinence and Medication ResponseP50CA143187 · NCI · UNIVERSITY OF PENNSYLVANIA · PI AUDRAIN-MCGOVERN, JANET E · 2009 to 2013
$8.6M
Fox Chase Cancer Center CCOP-Research Base ProgramU10CA101178 · NCI · FOX CHASE CANCER CENTER · PI ENGSTROM, PAUL FREDERICK · 2003 to 2008
$4.2M
An Effectiveness Trial of Maintenance Therapy for Nicotine DependenceR01DA025078 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI SCHNOLL, ROBERT ADAM · 2009 to 2013
$3.1M
Assessment of a Teachable Moment for Smoking CessationR01CA126969 · NCI · UNIVERSITY OF PENNSYLVANIA · PI SCHNOLL, ROBERT ADAM · 2007 to 2011
$1.7M
Assessment of High Dose Transdermal Nicotine for Fast Metabolizers of NicotineR21DA026889 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI SCHNOLL, ROBERT ADAM · 2009 to 2010
$433k
NCI NIH HHS P50 CA143187NCI NIH HHS R01 CA126969NCI NIH HHS U10 CA101178NIDA NIH HHS R01 DA025078NIDA NIH HHS R21 DA026889NIDA NIH HHS R21DA026889PHS HHS U10 101178
6 · The paper itself

Abstract

aimTo examine changes in nicotine withdrawal, nicotine craving, self-efficacy to quit smoking, and perceived control over withdrawal symptoms as predictors of smoking cessation following behavioral counseling and nicotine replacement therapy in a sample of smokers. DESIGN AND

settingThe data were ascertained from a randomized effectiveness trial comparing nicotine patch to nicotine lozenge. Predictors of smoking cessation were assessed at baseline and 5 weeks post-baseline, and 24-hour point prevalence abstinence, biochemically confirmed, was assessed at the end-of-treatment (week 15) and 6 months after a target quit date (week 27).

participants642 treatment-seeking smokers randomized to 12 weeks of nicotine patch or nicotine lozenge.

findingsParticipants who showed a greater increase in self-efficacy to quit smoking (OR=1.09, 95% CI: 1.02-1.16, p=.01) and perceived control over withdrawal symptoms (OR=1.02, 95% CI: 1.00-1.04, p=.05) were significantly more likely to have quit smoking at week 15. Participants who showed a greater increase in self-efficacy to quit smoking (OR=1.04, 95% CI: 1.01-1.06, p=.01) were significantly more likely to have quit smoking at week 27. Changes in withdrawal symptoms and craving were not related to week 15 or week 27 abstinence rates.

conclusionsThe results highlight two relatively under-studied potential psychological predictors of abstinence following treatment for nicotine dependence. Behavioral counseling interventions to promote smoking cessation should help smokers develop confidence in their ability to quit smoking and increase their sense of control over withdrawal symptoms to increase their chances for cessation.

Indexed as

Self EfficacyAdministration, CutaneousAdministration, OralAdultBehavior TherapyFemaleHumansMaleNicotinic AgonistsProspective StudiesSmokingSmoking CessationSubstance Withdrawal SyndromeTobacco Use DisorderTreatment OutcomeUnited StatesNicotinic Agonists

Identifiers

PMID20869812
PMCPMC2981675
OpenAlexW2093027289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.